Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $49.0950 (4.03%) ($49.0950 - $49.1350) on Fri. Jul. 15, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.69% (three month average) | RSI | 57 | Latest Price | $49.0950(4.03%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -1.1% a day on average for past five trading days. | Weekly Trend | HALO advances 3.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(43%) IWM(38%) IWO(38%) IWN(37%) IFRA(35%) | Factors Impacting HALO price | HALO will decline at least -1.345% in a week (0% probabilities). VIXM(-15%) UUP(-9%) VXX(-6%) TBT(-2%) TLT(2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.345% (StdDev 2.69%) | Hourly BBV | 0.6 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $48.87(0.46%) | 10 Day Moving Average | $48.43(1.37%) | 20 Day Moving Average | $47.02(4.41%) | To recent high | -5.2% | To recent low | 31.4% | Market Cap | $6.71b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |